74% revenue growth in the USA, clearly the doctors love the procedure. If that figure were released without the LCD bit I'm sure the price would already be well above 50c! Shame. Short term there will be uncertainty but the longer term picture is quite clear I reckon
At a valuation of now less than 1.5x revenue (less considering the increase in revenue) this seems incredibly cheap for a high revenue high growth high margin company with a massive R&D pipeline
- Forums
- ASX - By Stock
- Ann: Update on Proposed USA Medicare Changes
EYE
nova eye medical limited
Add to My Watchlist
4.17%
!
12.5¢

74% revenue growth in the USA, clearly the doctors love the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
12.5¢ |
Change
0.005(4.17%) |
Mkt cap ! $35.51M |
Open | High | Low | Value | Volume |
12.0¢ | 12.5¢ | 12.0¢ | $70.91K | 584.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 268742 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 22056 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 268742 | 0.120 |
6 | 427932 | 0.115 |
5 | 671828 | 0.110 |
6 | 223371 | 0.105 |
6 | 295150 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 18584 | 1 |
0.130 | 104745 | 2 |
0.135 | 366584 | 3 |
0.140 | 346515 | 3 |
0.150 | 6000 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online